Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
327 studies found for:    gefitinib
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gefitinib retreatment
2 Recruiting Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gefitinib, Hydroxychloroquine
3 Completed Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Condition: Myelogenous Leukemia, Acute
Intervention: Drug: gefitinib
4 Completed
Has Results
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
Conditions: Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Oligodendroglioma
Interventions: Drug: gefitinib;   Radiation: radiation therapy;   Other: pharmacological study;   Other: laboratory biomarker analysis
5 Completed Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: Gefitinib
6 Active, not recruiting High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Gefitinib
7 Completed A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: celecoxib, gefitinib
8 Completed Gefitinib in Treating Children With Refractory Solid Tumors
Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: gefitinib;   Other: pharmacological study;   Other: laboratory biomarker analysis
9 Recruiting First Line Gefitinib by FDG-PET Metabolic Response
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gefitinib
10 Completed ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
Condition: Skin Cancer
Intervention: Drug: Iressa
11 Completed A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: ZD1839
12 Recruiting Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Docetaxel
13 Completed Erlotinib Versus Gefitinib in Advanced Non Small Cell Lung Cancer With exon21 Mutation:A Randomized Trial
Condition: Thoracic Neoplasms
Interventions: Drug: erlotinib;   Drug: gefitinib
14 Recruiting Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC
Condition: Non-small-cell Lung Cancer
Intervention: Drug: Gefitinib
15 Terminated Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
Interventions: Drug: Iressa Day 1 given with Arimidex and Faslodex;   Drug: Iressa Day 21 given with Arimidex and Faslodex
16 Recruiting Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Conditions: Non-small Cell Lung Cancer;   Effects of Chemotherapy
Interventions: Drug: Gefitinib group;   Drug: Vinorelbine, Ifosfamide, Mesna
17 Completed Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Drug: gefitinib;   Radiation: radiation therapy;   Other: laboratory biomarker analysis
18 Completed
Has Results
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention: Drug: Gefitinib + Sunitinib
19 Completed
Has Results
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
Condition: Esophageal Cancer
Intervention: Drug: ZD1839
20 Completed Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: simvastatin;   Drug: gefitinib only

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years